Geode Capital Management, LLC Indaptus Therapeutics, Inc. Transaction History
Geode Capital Management, LLC
- $1.24 Trillion
- Q1 2025
A detailed history of Geode Capital Management, LLC transactions in Indaptus Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 124,967 shares of INDP stock, worth $1.24 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
124,967
Previous 82,118
52.18%
Holding current value
$1.24 Million
Previous $69,000
1.45%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding INDP
# of Institutions
18Shares Held
687KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA256KShares$2.54 Million0.0% of portfolio
-
Investment House LLC Las Vegas, NV129KShares$1.28 Million0.0% of portfolio
-
Strategy Asset Managers LLC45.3KShares$449,2790.0% of portfolio
-
Pine Valley Investments LTD Liability CO Marlton, NJ43.9KShares$435,2570.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny28.5KShares$282,4350.0% of portfolio
About Indaptus Therapeutics, Inc.
- Ticker INDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,258,600
- Market Cap $81.8M
- Description
- Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B v...